337 related articles for article (PubMed ID: 31078321)
1. Pharmacological Modulation of Transcriptional Coregulators in Cancer.
Bishop TR; Zhang Y; Erb MA
Trends Pharmacol Sci; 2019 Jun; 40(6):388-402. PubMed ID: 31078321
[TBL] [Abstract][Full Text] [Related]
2. Transcription factors and chromatin proteins as therapeutic targets in cancer.
Johnston SJ; Carroll JS
Biochim Biophys Acta; 2015 Apr; 1855(2):183-92. PubMed ID: 25721328
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptors and coregulators in inflammation and cancer.
Lee JS; Kim KI; Baek SH
Cancer Lett; 2008 Aug; 267(2):189-96. PubMed ID: 18433989
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor coregulators as a new paradigm for therapeutic targeting.
Hsia EY; Goodson ML; Zou JX; Privalsky ML; Chen HW
Adv Drug Deliv Rev; 2010 Oct; 62(13):1227-37. PubMed ID: 20933027
[TBL] [Abstract][Full Text] [Related]
5. Bromodomains: Structure, function and pharmacology of inhibition.
Ferri E; Petosa C; McKenna CE
Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
[TBL] [Abstract][Full Text] [Related]
6. Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situation and future directions.
Jin W; Tan H; Wu J; He G; Liu B
Drug Discov Today; 2022 Jan; 27(1):246-256. PubMed ID: 34438075
[TBL] [Abstract][Full Text] [Related]
7. The mechanisms behind the therapeutic activity of BET bromodomain inhibition.
Shi J; Vakoc CR
Mol Cell; 2014 Jun; 54(5):728-36. PubMed ID: 24905006
[TBL] [Abstract][Full Text] [Related]
8. Targeting GLI Transcription Factors in Cancer.
Didiasova M; Schaefer L; Wygrecka M
Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
Morrison AJ
FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Coregulation of Androgen Receptor Signaling.
Fernandes RC; Leach DA; Bevan CL
Adv Exp Med Biol; 2022; 1390():277-293. PubMed ID: 36107325
[TBL] [Abstract][Full Text] [Related]
11. Targeting the transcription factor Myb by small-molecule inhibitors.
Uttarkar S; Frampton J; Klempnauer KH
Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
[TBL] [Abstract][Full Text] [Related]
12. Targeting TOR dependence in cancer.
Janes MR; Fruman DA
Oncotarget; 2010 May; 1(1):69-76. PubMed ID: 20657741
[TBL] [Abstract][Full Text] [Related]
13. Targeting transcription factors by small compounds--Current strategies and future implications.
Hagenbuchner J; Ausserlechner MJ
Biochem Pharmacol; 2016 May; 107():1-13. PubMed ID: 26686579
[TBL] [Abstract][Full Text] [Related]
14. Drugging the undruggable: transcription therapy for cancer.
Yan C; Higgins PJ
Biochim Biophys Acta; 2013 Jan; 1835(1):76-85. PubMed ID: 23147197
[TBL] [Abstract][Full Text] [Related]
15. HSF1-mediated regulation of tumor cell apoptosis: a novel target for cancer therapeutics.
Kumar S; Tomar MS; Acharya A
Future Oncol; 2013 Oct; 9(10):1573-86. PubMed ID: 24106905
[TBL] [Abstract][Full Text] [Related]
16. ATAD2 in cancer: a pharmacologically challenging but tractable target.
Hussain M; Zhou Y; Song Y; Hameed HMA; Jiang H; Tu Y; Zhang J
Expert Opin Ther Targets; 2018 Jan; 22(1):85-96. PubMed ID: 29148850
[TBL] [Abstract][Full Text] [Related]
17. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.
Lambert JP; Picaud S; Fujisawa T; Hou H; Savitsky P; Uusküla-Reimand L; Gupta GD; Abdouni H; Lin ZY; Tucholska M; Knight JDR; Gonzalez-Badillo B; St-Denis N; Newman JA; Stucki M; Pelletier L; Bandeira N; Wilson MD; Filippakopoulos P; Gingras AC
Mol Cell; 2019 Feb; 73(3):621-638.e17. PubMed ID: 30554943
[TBL] [Abstract][Full Text] [Related]
18. Core transcriptional regulatory circuitries in cancer.
Chen Y; Xu L; Lin RY; Müschen M; Koeffler HP
Oncogene; 2020 Oct; 39(43):6633-6646. PubMed ID: 32943730
[TBL] [Abstract][Full Text] [Related]
19. Cell surface GRP78 signaling: An emerging role as a transcriptional modulator in cancer.
Gopal U; Pizzo SV
J Cell Physiol; 2021 Apr; 236(4):2352-2363. PubMed ID: 32864780
[TBL] [Abstract][Full Text] [Related]
20. Enhancer rewiring in tumors: an opportunity for therapeutic intervention.
Richart L; Bidard FC; Margueron R
Oncogene; 2021 May; 40(20):3475-3491. PubMed ID: 33934105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
